InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Renninger Robert. Insider active across 2 companies, notably Athira Pharma, Inc.. In total, 4 disclosures have been recorded. History available since 18 November 2024. The latest transaction was filed on 3 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Renninger Robert is Chief Financial Officer at Athira Pharma, Inc. and CHIEF FINANCIAL OFFICER at LeonaBio, Inc. The declarant has 4 filings in total, and across the 4 sampled filings the modal transaction nature is Attribution, with buy and sell amounts of EUR 0, over the period from 2025-01-03 to 2026-03-05.